Categories: News

Outset Medical to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Interim Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 5, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7927579. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Lynn Lewis or Brian Johnston

Gilmartin Group

investors@outsetmedical.com

Staff

Recent Posts

Orpyx to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Orpyx, a med tech + touch company…

14 hours ago

Asia Green Biotechnology Corp. Announces Change of Auditor And Discontinuation of Operations in Asia

CALGARY, AB / ACCESSWIRE / April 12, 2024 / Asia Green Biotechnology Corp. ("AGB" or…

14 hours ago

Beauty-Stem Biomedical Celebrates Grand Opening in Arcadia, Los Angeles

Beauty-Stem Biomedical, a cutting-edge stem cell supplement company, marked a momentous occasion with its grand…

14 hours ago

Community Fundraiser Hosted by CFC in Support of Infertility Awareness Week

Canadian Fertility Consulting and Fertility Matters Canada Unite for Virtual Paint Night FundraiserTORONTO, ON /…

14 hours ago

Akanda Announces Plans to Enter Blockchain and AI Technology Sector

London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

20 hours ago

LIVIN Foundation Teams Up With Healthtek, Inc. and Leading Non-Profits to Launch Revolutionary Suicide Prevention Platform

MINNEAPOLIS, MN / ACCESSWIRE / April 12, 2024 / LIVIN Foundation, a Minnesota-based non-profit and…

20 hours ago